carboplatin, pemetrexed disodium, and bevacizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for carboplatin, pemetrexed disodium, and bevacizumab, covering 2019-05-16 to 2019-05-16. Get the full timeline:
Most recent: Clinical Trial Update: Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]